Email Print Share
July 24, 2012

New Drug Delivery Technology

This illustration depicts nanolipogel, a new drug transport technology developed at Yale University with National Science Foundation (NSF) support, administering its immunotherapy cargo. The light-blue spheres within the blood vessels and the cutaway sphere in the foreground are the nanolipogels (NLGs). As the NLGs break down, they release IL-2 (the green specks), which helps recruit and activate a body's immune response (the purple, sphere-like cells). The tiny, bright blue spheres are the additional treatment, a cancer drug that inhibits TGF-beta (one of cancer's defense chemicals).

The research was led by Tarek Fahmy, a Yale University engineering professor and an NSF Faculty Early Career Development (CAREER) program awardee. To learn more, see NSF press release 12-129, Elegant Delivery. (Date of Image: 2012)

Credit: Nicolle Rager Fuller, NSF


Images and other media in the National Science Foundation Multimedia Gallery are available for use in print and electronic material by NSF employees, members of the media, university staff, teachers and the general public. All media in the gallery are intended for personal, educational and nonprofit/non-commercial use only.

Images credited to the National Science Foundation, a federal agency, are in the public domain. The images were created by employees of the United States Government as part of their official duties or prepared by contractors as "works for hire" for NSF. You may freely use NSF-credited images and, at your discretion, credit NSF with a "Courtesy: National Science Foundation" notation.

Additional information about general usage can be found in Conditions.

Also Available:
Download the high-resolution JPG version of the image. (1.4 MB)

Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.